RK-10
RK-10 is a PD-L1 binding peptide. RK-10 conjugated with Cy5 (HY-D0821) or Biotin (HY-B0511) can used to detect PD-L1 expressing tumors with flow cytometry or immunohistochemistry. RK-10 can be used for cancers like NSCLC, breast cancer, squamous cell carcinoma and melanoma detection research.
For research use only. We do not sell to patients.
- CAS No.: 2222260-53-7
- Formula: C105H176N28O36S
- Molecular Weight:2438.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
CAS No. 2222260-53-7
-
Molecular Weight 2438.75
-
Formula C105H176N28O36S
-
Sequence
Gly-Ser-Gly-Ser-Gly-Ser-Thr-Tyr-Leu-Cys-Gly-Ala-Ile-Ser-Leu-Ala-Pro-Lys-Ala-Gln-Ile-Lys-Glu-Ser-Leu
-
Sequence Shortening
GSGSGSTYLCGAISLAPKAQIKESL
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Polymer-Based Two-Step IHC Detection
Polymer-based two-step IHC detects tissue antigens by first binding an unlabeled primary antibody to the antigen and then applying an HRP-polymer secondary reagent that carries multiple secondary antibodies and HRP molecules on a polymer backbone; the localized HRP converts chromogens such as DAB or AEC into visible deposits for light-microscopic interpretation. The method is \"two-step\" because the primary antibody step is followed directly by the polymer-enzyme secondary reagent, rather than by separate secondary-antibody and avidin-biotin complex steps; published comparisons reported similar or higher sensitivity than several multistep systems and avoidance of endogenous-biotin interference.
-
Flow Cytometry
Flow cytometry (FC) is a technique for high-speed, step-by-step quantitative analysis and sorting of single cells or other biological particles in a suspension by detecting labeled fluorescent signals.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Avidin-Biotin/Streptavidin-Biotin IHC
Avidin-biotin or streptavidin-biotin immunohistochemistry detects tissue antigens by binding a primary antibody to the target antigen, then detecting that antibody with a biotinylated antibody and an avidin-biotin-enzyme or streptavidin-enzyme detection complex; the enzyme reaction produces a visible chromogenic deposit at the antigen site for light-microscopic localization. The classic ABC method uses the high-affinity avidin-biotin interaction to bridge biotinylated secondary antibody and biotinylated peroxidase, and early comparative studies reported stronger immunoperoxidase staining than PAP-based methods in formalin-fixed tissue sections.
-
Protocol for Phospho-flow cytometry
Phospho-flow cytometry detects intracellular phosphorylated signaling proteins in single cells using phospho-specific antibodies after rapid fixation and permeabilization; the fluorescence intensity reflects phosphorylation state and therefore kinase-pathway activation, inhibition, or drug response in defined cell subsets. Unlike Western blot, phospho-flow preserves single-cell resolution and can measure signaling heterogeneity in cancer cells, primary immune cells, dissociated mouse tumors, macrophages, organoid-derived cells, and drug-screening samples when validated antibodies and fixation/permeabilization conditions are used.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)